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SUMMARY
A review of the literature on primary cardiac amyloidosis
is presented. Its differentiation from constrictive pericar-
ditis, both on clinical and haemodynamic grounds, is out-
lined. The importance of antemortem endomyocardial
biopsy in establishing a definitive diagnosis of this rela-
tively rare condition is stressed. Finally, an updated
overvie,!" of the classification and immunological patho-
genesis of this disease is given.
S. Air. med. J., 57, 831 (1980).
CLASSIFICATION OF AMYLOIDOSIS
Several different systems of classification of amyloidosis
have been described:-3 reflecting the unexplained patho-
genesis. Previous attempts to classify the condition on
the basis of the postmortem distribution of involved
organs have been superseded by a working classification
which recognizes that clinical manifestations may overlap
a great deal. The following classification may be employed:
(a) primary amyloidosis - with or without associated
plasma cell and lymphoid neoplasm; (b) secondary amy-
loidosis - associated with chronic disease such as tuber-
culosis, ulcerative colitis, syphilis, osteomyelitis, or rheuma-
toid arthritis; (c) familial systemic amyloidosis, as in
familial Mediterranean fever and Portuguese limb neuro-
pathy; (d) amyloidosis associated with ageing ('senile amy-
loidosis'); (e) amyloidosis of endocrine glands, as in
medullary thyroid carcinoma and multiple endocrine
neoplasia.
Previously there was doubt whether primary amyloi-
dosis represented a distinct entity, and it was suggested
that primary amyloidosis was a pathological variant of
primary plasma cell proliferation: since amyloid deposits
often precede the skeletal manifestations of multiple
myeloma. They may be classified together because of the
presence of the 'amyloid L chain' protein in primary and
myeloma-associated amyloidosis.
Senile amyloidosis' corresponds to the condition which
develops in younger people after infection, for example
tuberculosis or lymphogranulomatosis but, like primary
amyloidosis, it need not be associated with infections. The
senile amyloidotic triad consists of amyloid deposition in
brain, cardiac muscle and pancreatic islets. The number
of organs involved increases with ageing, but in contrast
to secondary amyloidosis, spleen, liver and kidney are
usually unaffected.
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AETIOLOGY AND PAmOGENESIS
The homogeneous extracellular eosinophilic material which
characterizes amyloidosis may be derived from several
proteins, including L-chain fragments and hormones. It
consists of long fibrils with a diameter of 100 - 150 A
arranged in an antiparallel and B-pleated sheet struc-
ture."'; Amyloid depOSits may originate from a precursor
protein present in the circulation or from a locally pro-
duced protein. The possibility that primary and secon-
dary amyloidosis may share a common pathogenetic
mechanism, associated with an underlying immune dis-
order, remains to be disproved.
Amyloid fibrils appear to be composed of two types
of protein, singly or in combination. Primary amyloid
is composed of fragments of immunoglobulin light
chains which may arise from overproduction of, or failure
ot: degradation of, light chains in serum. The amyloid
fibrils may be separated into lambda and kappa types,
hut the frequency of lambda-related proteins is greater
than that of protein of the kappa-chain class. The proteim
comprising primary amyloid are called the amyloid L-
chain (AL) proteinS.' and have a molecular weight of
5 000 - 25 000 daltons. Amyloid deposits appear to be
derived directly from this circulating precursor, which is
also found in the myeloma-associated amyloid.
In contrast, overproduction of an unrelated protein,
amyloid A (AA) protein, is associated with secondary
amyloidosis and familial forms, for example, familial
Mediterranean fever. AA protein appears to be derived
from an antigenically related large protein, the serum
amyloid A-related (SAA) protein with molecular weight
of 12 000 - 14000 daltons, while AA protein has a
molecular weight of 8 000 daltons. SAA is produced in
response to B Iymphocyte stimulation. SAA and AA
protein are cleaved by proteases liberated by monocytes
to small peptides or AA-like molecules. Individuals appear
to vary in their ability to process these intermediate pro-
ducts and those in whom AA intermediates persist appear
to have a predisposition to develop amyloid under condi-
tions of increased SAA production. Variations in the
ability to degrade SAA may be genetically determined,
but could also be influenced by the presence of protease
inhibitors which normally inhibit SAA and AA degrada-
tion, except in several disease states during which their
activity falls.
The concentration of SAA increases with ageing, values
at the 8th or 9th decade being 10 times greater than in
the first 5 decades. Its concentration increases during
chronic diseases including amyloidosis, infections, cancer,
rheumatoid arthritis, multiple myeloma, macroglobulinae-
mia, lymphoma and pregnancy. It behaves as an acute
phase reactant after acute infections or acute-on-chronic
infections, when its level quickly returns to normal. In
addition a similar fibrillary structure may be formed from
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insulin and glucagon. Also, thyrocalcitonin has been
identified in the amyloid of medullary carcinoma of the
thyroid gland.
It has also been postulated that amyloid may be syn-
thesized in the tissues which reflect its distribution. A
locally synthesized precursor may produce L-chain im-
munoglobulins which, when processed, form the charac-
teristic fibrillary structure adjacent to sites of synthesis,
for example, in the vicinity of massive plasma cell in-
filtrates. Most amyloid deposits also contain a minor
component, the 'p' or 'doughnut' component, a protein
with a molecular weight of 180000 daltons whose sig-
nificance is at present unclear.
It has recently been postulated that amyloidosis is a
primary disorder of the immune system,'·'" and that the
manifestations of primary and secondary amyloidosis
merely reflect differences in the degree of antigenic
stimulation of the reticulo-endothelial system. Support
for this hypothesis is based on the association between
primary amyloidosis and plasma cell dyscrasias, while
secondary amyloidosis is accompanied by excess im-
munoglobulin production in rheumatoid arthritis, tuber-
culosis, and leprosy (Hansen's disease). Experimental
studies in mice appear to suggest that disturbed immuno-
regulatory function plays an important role in amyloidosis.
It has been proposed that macrophage activation by
Iymphokines represents the initial step in the pathogenesis
of amyloid disease. Massive short-term antigenic stimula-
tion of the reticulo-endothelial system leads to accumula-
tion and deposition of AA protein in connective tissue,
possibly accompanied by immunoblast proliferation and
T-cell suppression.
Less intense but more sustained stimulation of the
macrophages results in monoclonal proliferation of plasma
cells and L-chain deposition in the form of amyloid
fibrils.
Tormal T-cell function inhibits amyloid disease by
controlling excessive macrophage activation and B-cell
proliferation despite constant antigenic challenge. Definite
proof of synthesis of amyloid by B-cells or macrophages
is lacking, but both primary and secondary amyloid may




The macroscopic and microscopic features of cardiac
amyloidosis have been fully and frequently documented."
Like other organs affected by amyloidosis, the heart
tends to be peculiarly firm, and its weight moderately
increased. Any part of the heart may be affected and
the amount of amyloid varies greatly. The pericardium is
frequently involved. The endocardium is sometimes
affected and amyloid may extend to the valvular as well
as the parietal endocardium. The greatest amount of
amyloid, however, is found in the myocardium of both
atria and ventricles. The myocardium is peculiarly stiff,
as -if fixed, so that the chambers do not collapse. Pre-
sumably this decrease in myocardial compliance is the
main factor· responsible for the restricted ventricular
filling.
Vascular involvement varies from occa'sional segmental
lesions in the media to extensive. replacement of all coats
of the vessel wall and myocardial ischaemic fibrosis.
Under the light microscope, in the average case, the
heart muscle cells are surrounded by rings of amyloid
apparently deposited on the cell surface or on the
reticulum framework. In very severe cases the myocardial
fibres appear necrotic, atrophic or completely replaced
by amyloid. In the less damaged areas surviving fibres
may show hypertrophy. Patchy amyloid in the myocardium
is not uncommonly found post mortem in old people but
does not commonly cause deterioration of cardiac func-
tion." The ultrastructural features have been described:"
the amyloid was fibrillary and beaded with fibrils varying
in width from 140 to 450 A. Some fibrils were-disposed
haphazardly, while others were arranged in bundles. The
amyloid deposits were present in relation to the basement
membranes of heart muscle cells, around capillaries and
in the interstitial tissues. No instance of intracellular
amyloid was observed.
Clinical Features
The clinical presentation of primary cardiac amyloidosis
is essentially that of a 'restrictive' cardiomyopathy (or
'stiff heart' syndrome) in a patient generally older than
50 years. Exertional dyspnoea is the most common early
symptom but as the disease progresses orthopnoea
usually appears. Paroxysmal cardiac (nocturnal) dyspnoea
is fairly common, occurring when the disease process
affects predominantly the left side of the heart, and the
majority of patients present with symptoms of cardiac
failure. Palpitations with or without syncopal episodes
secondary to an arrhythmia may be the presenting com-
plaint. Congestive cardiac failure develops in more than
half of these cases and is usually insidious. The average
duration of symptoms in these cases is 14 months." It is
important to appreciate that the clinical features of the
cardiomyopathy (and even other types of cardiomyopathy,
to a lesser degree) may mimic those of constrictive peri-
carditis."'-"'" Thus, Kussmaul's sign (paradoxical increased
distension of neck veins on inspiration) may be present
but is certainly not pathognomonic of 'restrictive' cardio-
myopathy. Some astute examiners will notice that the 'a'
and 'v' waves are prominent, followed by a deep and
steep early diastolic 'y' descent and a shallow but less
steep systolic 'x' descent. Pulsus paradoxus, as in con-
strictive pericarditis and other conditions such as severe
acute asthma, is also seen.
Arterial hypotension"'''' may be either supine or ortho-
static in nature and occurred in some 12 % of.a series of
118 patients," indicating that it is not a reliable sign of
cardiac involvement. In another series'" of 15 patients
hypotension was seen only in those with renal or gastro-
intestinal disease or peripheral neuropathy; tbis symptom
may be a clue to involvement of these systems." The
clinical features of primary cardiac amyloidosis may also
be very closely simulated in constrictive endocarditis
(endocardial fibro-elastosis, endomyocardial fibrosis and
Loeffler's endocarditis).
Ischaemic heart disease may be incorrectly diagnosed
in some patients because of typical or atypical angina
pectoris.""3l,,. Pseudomyocardial infarction patterns have
also been described (see 'Electrocardiograpruc Features').
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On examination the apex beat is unremarkable with
little precordial pulsation. The heart soun( 3 are usually
soft but can be of normal intensity. A rematkable feature
on auscultation at the pulmonary area is the behaviour
of the second heart sound. On inspiration there appears
to be a 'quickening' of the pulmonic component due to
the aortic component moving away from it, rather than
the pulmonic component coming closer (see 'Phono-
cardiography'). This physical sign is also quite characteris-
tic of constrictive pericarditis. Additional diastolic sounds
are common and suggest the presence of restriction. This,
can, however, be confused with the 'pericardial knock'
of constrictive pericarditis which occurs earlier during
diastole. Murmurs are conspicuous by their absence, but
rheumatic valvular heart disease may be mimicked by
the presence of mitral pansystolic murmurs as in our
case.'· Cqntroversy exists as to whether such valvular
abnormalities can contribute or give rise to cardiac dys-
function. "'.25.'.
Patients with 'restrictive' ('constrictive') cardiomyopathy
may at some stage also show features of 'congestive'
cardiomyopathy with progression of the disease." Mural
intraventricular thrombosis with subsequent systemic
embolism has been described.ss Another possible con-
sequence of development of a mural thrombus is organiza-
tion of the latter, with replacement fibrosis contributing
further to the restrictive process.
Electrocardiographic Features
It is generally accepted that the ECG is always abnor-
mal in patients affected by primary cardiac amyloidosis"''''
but there is no pathognomonic pattern. Low-voltage QRS
complexes, especially in the standard extremity leads, are
the most common abnormality in most series,"'·4' pro-
bably due to extensive infiltration and replacement
fibrosis of myocardia1 tissues.
Disturbances of atrioventricular conduction are most
varied and heart block is prominent. ""',4','3 Some workers
have correlated the anatomical findings of amyloid in-
filtration of the conduction system with the electrocardio-
graphic conduction abnormalities.""'··" Involvement of
the sino-atrial node, with or without concomitant atrio-
ventricular node involvement, has also been described.50
Classic cases of sick sinus syndrome, manifesting with a
variety of supraventricular arrhythmias and causing
syncopal episodes, are less frequently documented.51 • s•
Atrial fibrillation is classically associated with cardiac
amyloidosis, especially at the advanced stage with cardiac
failure. Other arrhythmias, such as atrial flutter, supraven-
tricular tachycardia and junctional tachycardias, are fairly
common. The most dangerous arrhythmias are commoner
in patients on digitalis therapy: who are stated to be
more sensitive to this drug in the presence of cardiac
amyloidosis.H.31." Intriguing are the changes mimicking
old transmural myocardial infarction;" these are usually
anteroseptal or anterior in site, and are thought to be
due to the atrophy and widespread replacement of myo-
cardium by amyloid material, as several of these patients
have patent coronary arteries at postmortem examination.
Left axis deviation is often present as well. Of interest is
the rare electrocardiographic finding of electrical alterna-
tion of the p wave, first described by Bernreiter."
Thus, in summary, the presence of low QRS voltage
in the limb leads, accompanied by inversion of the QRS
complexes in the right precordial leads, should alert one
to the possibility of cardiac amyloidosis whether symp-
toms are present or not.
Phonocardiography
Premature closure of the aortic valve in primary cardiac
amyloidosis was described for the first time by the
present authors."" This feature,' initially thought to be
characteristic of constrictive pericarditis,'" is probably due
to the relative non-compliance of atria and ventricles,
thus causing an altered pressure-volume relationship.
Echocardiographic Features
The advent of echocardiography has made possible the
presymptomatic detection of many conditions, especially
the cardiomyopathies. Characteristic features have been
well documented in the hypertrophic cardiomyopathies,
obstructive or non-obstructive, as well as the congestive
cardiomyopathies. More recently, Borer et al." have
delineated the changes seen in the infiltrative cardio-
myopathies,"' as exemplified by amyloidosis. This latter
group of conditions gives rise to so-called 'restrictive'
features. 63 With cardiac amyloidosis, specifically, there is
marked thickening of the ventricular walls which gives
rise to a non-compliant and 'stiff' ventricle (especially the
left) displaying a usually normal cavity size. Because of
reduced left ventricular compliance the left atrium is as a
rule dilated.'"
Decreased diastolic compliance of the left ventricle
leads to increased resistance to early diastolic filling with
subsequent reduction in the 'mitral valve slope' (E-F
slope)." This measurement was one of the earliest reported
with regard to mitral valve motion.""'" Quinones et al."
demonstrated that an E-F slope of less than 60 mm/s
(normal range 60 - 110 mm/s) in the absence of mitral
valve obstruction, was closely correlated with impaired
left ventricular filling secondary to decreased diastolic
compliance. However, a reduced mitral valve slope is also
seen in mitral stenosis, atrial myxoma, aortic stenosis,
aortic insufficiency, primary pulmonary hypertension, and
idiopathic subaortic stenosis.·..·•• Recently, this reduction
has also been reported in scleroderma heart disease."'·71
Borer et al.'" demonstrated that the left ventricular free
wall and septum were thickened (more than 11 mm) in all
of their 19 patients with infiltrative disease of the heart
(4 of whom had systemic amyloidosis). However, the
septal/posterobasal free wall thickness ratio" was always
less than 1,3. Contractility of the left ventricle, as repre-
sented by the ejection fraction, was preserved (exceeded
60%) in 18 of the 19 cases. Other studies""" have also
shown reduced ventricular wall motion with a striking
increase in the septal and free posterior wall thickness
(but with normal ratios) in the absence of ventricular
dilatation.
Some workers""· have stressed abnormal or paradoxical
interventricular septal motion (movement of the septum
anteriorly during systole) as a feature of constrictive
pericarditis. Although this was noted in some of the
patients of Voelkel et al." it was regarded as not specific,
having been described following cardiopulmonary bypass,"
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and also in ischaemic heart disease, conduction defects
and right ventricular volume overload."
It is interesting to note that a pattern of diastolic
posterior wall 'flatness', which might be expected to
occur with infiltrative diseases causing subsequent myo-
cardial restriction, was not a significant feature in two
recent series."""
Radiological and Angiographic Features
Pericardial effusion is an important presenting feature
in primary cardiac amyloidosis,...·.. although this has been
somewhat neglected in previous published reports. Diffi-
culty may well be experienced in differentiating a peri-
cardial effusion from a thickened myocardium ('water-
bottle shape' heart), especially if radio-isotopic examina-
tions are performed only in the anteroposterior position.
Thus, on account of the marked myocardial thickening,
rectilinear and scintillation scanning may well demonstrate
the 'halo' or 'horseshoe' deformity surrounding the cardiac
blood pool, increased spacing between the heart and liver,
and a reduced cardiac diameter when this is contrasted
with that seen on the plain radiograph. Tevertheless, this
important potential misinterpretation may be avoided by
taking additional radioscans in the left anterior oblique
projection, which then allows clear visualization of any
thickening of the interventricular septum.'" An additional
differentiating point between these two pathological pre-
sentations is that of 'snubbing' of the left ventricular
blood pool seen with myocardial thickening secondary
to amyloidosis, myocardial hypertrophy, and even perhaps
with other infiltrative cardiomyopathies. Pericardial effu-
sion has also been seen in isolated cases post mortem"'·5'
but usually only if there is direct amyloid infiltration of
the pericardial tissues," or if the patient is in severe
congestive cardiac failure.
Significant cardiomegaly may also sometimes be caused
by predominant enlargement of the right atrium due to
dilatation secondary to markedly elevated right heart
pressures. Chew et al."" reported a similar situation.
Therefore, care must be taken not to misinterpret this
right atrial dilatation as a pericardial effusion.
Primary cardiac amyloidosis is often associated with
amyloid deposits in the perivascular space and interstitium
of the lungs; the latter may mimic and be radiologically
indistinguishable from pulmonary congestion. -86 The dis-
tinction between these two conditions may be further
complicated by the fact that the cardiac failure of pri-
mary cardiac amyloidosis is generally refractory to therapy
and thus the radiological signs of 'pulmonary congestion'
may remain. Furthermore, because amyloidosis gives rise
to a disseminated interstitial pulmonary picture it must
be considered in the differential diagnosis of such diseases
as miliary tuberculosis, eosinophilic granuloma, Iymphan-
gitic carcinoma and sarcoidosis. Calcifications and even
ossification have been noted in the pulmonary interstitium
infiltrated by amyloid deposits." This calcification may
well be missed on routine radiography but is usually
detected with tomography.
However, there are no characteristic radiological
appearances of amyloidosis within the lung and thus a
diagnosis can be firmly established only by biopsy and
microscopic examination of the tissue by spe~ial staining
techniques. Cine angiographic features of the cardiac
chambers, especially the ventricles, are usually highly
suggestive of amyloid infiltration. Trabeculation is, as a
rule, far more coarse and the papillary muscle impres-
sions are more marked, but cavity distortion is minimal
when compared with that seen in fairly advanced con-
strictive pericarditis. Systolic emptying of the ventricles
is also usually somewhat reduced in the absence of
increase in the end-diastolic volume. Right atrial cine
angiograms tend to demonstrate a moderately dilated
chamber despite the heavy infiltration of the atrial wall
by amyloid deposits. Calcification of the pericardium is
also absent, a feature which strongly differentiates this
condition from that of con trictive pericarditis, whether
tuberculous or otherwise.
Haemodynamic Features
Hetzel et al.'fS were the first to realize that the haemo-
dynamic changes seen with cardiac amyloidosis could
be identical to those so well described with constrictive
pericarditis;"'-" they ascribed these changes to 'altera-
tions in the distensibility characteristics of the myo-
cardium'. This is not surprising, as the 'constriction' in
amyloid heart disease is \vithin the myocardium itself,
rather than in the pericardium as in constrictive peri-
carditis.
The first haemodynamic study, carried out on a patient
with primary amyloidosis in 1950," demonstrated that the
amyloid heart was unable to augment its diastolic volume.
A few years later Gunnar et al." published the second
case of 'primary' amyloidosis with cardiac involvement;
because of a positive Mantoux test (l: 10 (00), the
patient had been started on antituberculosis therapy in
view of the strong likelihood of tuberculous constrictive
pericarditis, diagnosed prior to cardiac catheterization,
but the diagnosis proved to be multiple myeloma with
secondary amyloidosis. Haemodynamically the patient
showed severe right atrial hypertension, the contour of
the pressure curves taking on an 'M' or -'W' configuration.
The ventricular pressure curves had features of an 'in-
elastic and hypodynamic chamber'. So, although the peak
systolic pressure exceeded normal, it was certainly less
than anticipated with the high ventricular filling pressures
(i.e. the end-diastolic pressure). The contour of the dia-
stolic component of the ventricular pressure curve also
revealed impressive characteristics in that there was a
'early diastolic dip' followed by a 'diastolic plateau'_
Thus, the right atrial and ventricular pressure curves
indicated that the haemodynamic disorder consisted of
rapid emptying of the atria into the ventricles, especially
during the phase of ventricular isometric relaxation,
followed by a rapid rise in the diastolic ventricular
pressure, which stabilized to a higher than normal end-
diastolic value because of the limited distensibility of the
ventricle.
Elevation of the pulmonary capillary wedge pressure'
(indirect left atrial pressure) further indicated involve-
ment of the left side of the heart by the infiltrative
amyloid deposits. A reduced peak systolic left ventricular
pressure, as well as a narrow pulse pressure in the
systemic circulation, was evidence of reduced cardiac
output, which was further markedly reduced by exercise.
Therefore all the above haemodynamic findings have
17 Mei 1980 SA MEDIESE TYDSKRIF 835
-
been claimed to be 'characteristics' of constrictive peri-
carditis.
Some authors" went a step further in saying that the
end-diastolic pressure of the affected ventricle was greater
than one-third of the systolic pressure, but many
authors"''''' have found this claim to be inconsistent.
Often there is elevated pulmonary artery diastolic pres-
sure similar to pulmonary capillary wedge pressure, the
right ventricular end-diastolic pressure, and the right
atrial pressure. These are also known to occur with right
ventricular infarction.".97
The above haemodynamic features can be seen in a
wide spectrum of diseases such as sarcoidosis, haemo-
chromatosis, chronic myocarditis with fibrosis, endomyo-
cardial fibrosis, and primary amyloidosis associated with
Gaucher's disease." All these diseases eventually result
in re.striction to ventricular filling (the 'stiff heart' syn-
drome).
The differentiation of constrictive pericarditis from the
'restrictive'" cardiomyopathy of primary cardiac amyloi-
dosis on haemodynamic grounds is usually exceptionally
difficult, if not impossible.31 ,1()() At times there is asym-
metrical involvement of the heart by amyloid infiltration,
whereas there is usually symmetrical constriction by con-
strictive phicarditis. Also, a raised late diastolic pressure
in constrictive pericarditis is usually caused by a uniform
restriction of ventricular filling," whereas with restrictive
cardiac amyloidosis the raised right ventricular end-
diastolic pressure usually represents the transmission of
an exceptionally exaggerated 'a' wave. Therefore, a sig-
nificantly prominent 'a' wave is usually absent in con-
strictive pericarditis and may be strikingly raised with
primary cardiac amyloidosis. '•l It has also been stated that
with more myocardial involvement by a primary disease
process, especially of the left ventricle, the left atrial
'a' wave is usually some 10 - 20 mmHg greater than the
'a' wave in the right atrium." By contrast, the difference
between the right and left atrial 'a' waves in constrictive
pericarditis is usually less than 6 mmHg. Chew et al,'6
claimed that constrictive pericarditis and primary cardiac
amyloidosis could be clearly contrasted on haemodynamic
grounds. In the former there is a near-normal systolic
emptying phase with a normal end-systolic volume and
better preservation of stroke volume; rapid filling of the
ventricles in early diastole also gives rise to an early
third heart sound and there is little or no further filling
late in diastole. In constrictive pericarditis there is also a
low early left ventricular diastolic pressure which rises
early to a plateau, with a high mid-diastolic and end-
diastolic pressure and the absence of an 'atrial kick'.
Rapid ventricular filling allows the patient with constric-
tion to raise the cardiac output by a compensatory in-
crease in heart rate. Constrictive pericarditis more often
than not has similar left and right ventricular diastolic
pressures,'·' usually not found in primary cardiac amy-
loidosis. Chew et al:· went on to claim that 'restrictive
cardiomyopathy' (i.e, a small group of diseases with
diastolic filling disorder) can also be differentiated from
'amyloid heart', in that patients in the former group
do indeed resemble patients with constrictive pericarditis
but can be differentiated on the grounds of unequal in-
volvement of the two ventricles, the disease being more
often left-sided. Furthermore, patients with 'restrictive
cardiomyopathy' have normal systolic function, a normal-
sized heart, an early and loud third heart sound and
early filling of the left ventricle, which is rapid with
reduced early diastolic pressure, but which i,ncreases
abruptly with cessation of further filling during mid-
diastole or late-diastole. This group of patients is also
thought to have underlying endocardial disease; the re-
lationship to Loeffler's disease of temperate zones and
to endomyocardial fibrosis of the tropics awaits further
clarification.
Finally, Shabetai and Meaney"" reported that in both
cardiac amyloidosis and constrictive pericarditis, ejection
and isovolumic contraction were variable and thus did
not differentiate myocardial from pericardial restriction;
comparison of the left and right heart filling pressures
remained the most useful haemodynamic parameter with
which to distinguish between them.
Endomyocardial Biopsy in Diagnosis
Definite pathological diagnosis of myocardial disease
has, until fairly recently, been possible only by means of
open myocardial biopsy at tho~acotomy",5S,]{J4 with a per-
cutaneous needle technique,'·'·'·' or post mortem.'os, '.9
The introduction of the revolutionary Bioptome,lIO,lU
adapted to the intracardiac catheter, has allowed safer
acquisition of larger endomyocardial specimens and thus
led to more frequent use in investigative centres,""'"
especially in heart disease of obscure origin. Modifications
have been described which allow simpler percutaneous
insertion, especially into peripheral arteries."5 • m
The safety of the percutaneous Bioptome catheter
procedure for endomyocardial biopsy' compares most
favourably with that of other techniques. Cases of peri-
cardial tamponade, haemothorax and pneumothorax
secondary to cardiac perforation have been described in
the literature, but these complications are rare in ex-
perienced hands. The only other significant complication
is arrhythmia, which can be largely prevented by careful
manipulation of the catheter.
Hedner et al.Hs were the first to publish a case of
primary cardiac amyloidosis diagnosed by right ventricular
endomyocardial biopsy. Schroeder et al.'" then published
2 cases of secondary amyloidosis diagnosed by the same
procedure; Chew et al:· diagnosed secondary amyloidosis
by left ventricular endomyocardial biopsy, while Chan
and lkram"· diagnosed a case of primary amyloidosis by
the same method. The present authors subsequently pub-
lished" the second case of primary cardiac amyloidosis
in the world literature diagnosed by endomyocardial
biopsy of the right ventricle.
Differential Diagnosis
Perhaps the most important condition which needs to
be differentiated from primary cardiac amyloidosis is
chronic constrictive pericarditis, which is usually tuber-
culous'"'''' and initially gives rise to a pericardial effusion,
followed by constriction and tamponade. This diagnosis
is aided by positive skin tests and is definitive with a
positive pericardial biopsy.
The connective tissue abnormalities are known to cause
cardiomyopathy. Rheumatoid arthritis usually presents
with its peripheral manifestations and seldom involves
836 SA MEDICAL JOUR AL 17 May 1980
the heart from the outset. In contrast, systemic lupus
erythematosus (SLE) may present with cardiac involve-
ment, the most common being Libman-Sacks endocardi-
tis. In an autopsy series':>! of SLE 60 - 70% of cases
had pericarditis as a complication. Polyarteritis nodosa
may give ri e to a diffuse myocarditis, but more com-
monly local coronary arteritis causes areas of ischaemic
fibrosis; there have been various reports"'''' of endomyo-
cardial fibrosis in association with this disease. Sclero-
derma is also known to cause a pericardial effusion as
well as give rise to a 'restrictive' picture. Cardiac haemo-
chromatosis simulating constrictive pericarditis may well
be confused with amyloid infiltration of the heart. Sar-
coidosis may also cause some difficulty, especially as it
may also affect the conduction system, a known but
unusual complication of cardiac amyloidosis. Of interest
is the odd condition termed 'seroconstrictive pericarditis',''''
which may well be due to a system disease or even a
viral infection, i.e. 'relapsing viral pericarditis'. This is
characterized by recurrent pericardial effusions accom-
panied by a low-grade pyrexia. Treatment with repeated
pericardiocentesis is usually effective.
Idiopathic cardiomegaly may simulate primary cardiac
amyloidosis; both are characterized by cardiomegaly and
cardiac failure, usuaJJy without chest pain. In the former
condition intracardiac mural thrombi, with systemic and
pulmonary emboli, are common.
'Constrictive endocarditis' resembles cardiac amyloi-
dosis, which in turn can mimic constrictive pericar-
ditis. ",31.9••". Therefore, conditions such as Loeffler' endo-
carditis ('parietal fibroplastic endocarditis'), endomyo-
cardial fibrosis, endocardial fibro-elastosis, and Becker's
subendocardial fibro-elastosis ('South African cardio-
myopathy'),"" must be entertained in differential diagnosis.
All these diseases can give rise to a 'restrictive' clinical
picture" or 'stiff heart' syndrome.""
In some cardiomyopathies (especiaJJy idiopathic hyper-
trophic subaortic stenosis) there is often gross left
ventricular hypertrophy. The situation may give rise to a
'Bernheim effect' (bulging of the interventricular septum
into the right ventricular cavity with transmission of intra-
ventricular pressure from the left side), which presents
as large 'a' waves in the neck veins in the presence of
right-sided cardiac failure but usuaJJy in the absence of
dyspnoea. However, with idiopathic hypertrophic sub-
aortic stenosis the functional disorder differs from that
caused by amyloid infiltration in that there is preservation
of ejectile capacity (except in some of pre-terminal cases).
Treatment
To date there is no specific effective therapy for
primary cardiac amyloidosis. Since the most common
clinical presentation of this disease is congestive cardiac
failure, initial medical management consists of standard
diuretics with the addition of digitalis preparations. How-
ever, the cardiac failure is more often than not refractory
to therapy and death usually results from it or renal
failure or sometimes acute pulmonary embolism or
coronary embolism.
Treatment is further complicated by the fact that these
patients appear to be specificaJJy sensitive to digitalis
compounds. The first 2 cases of digitalis toxicity were
reported by Cassidy,"" Subsequent reports" have empha-
sized this peculiarity and underlined the importance of
being cautious in prescribing these preparations. This
unusual sensitivity may partly be due to infiltration of
the conduction system by amyloid deposits,'· thus poten-
tiating the chronotropic and dromotropic effects of
digitalis.
Another manifestation of conduction system involve-
ment is the sick sinus syndrome.""'oo Because of symptoms
of this complication permanent pacemakers have been
inserted without success.""'"
Since a further complication of primary cardiac amyloi-
dosis is systemic embolization originating from the atrial
or ventricular mural thrombi, antiplatelet agents and anti-
coagulants should also be considered in management.
More recently, cardiac transplantation has been enter-
tained. Schroeder et at.''' would have performed a trans-
plantation on their first patient if the rectal biopsy had
been negative, but unfortunately the latter indicated that
the patient had systemic involvement. The chance that
this operation would help is uncertain, while a heterotopic
('piggy-back') transplant would not ensure a return to
normal of a diseased heart, which would almost certainly
become more 'restrictive' with further amyloid infiltration.
On the other hand, with an orthotopic transplant there
would be the risk of organ rejection, leaving the patient
without any functioning heart.
If myocardial biopsy were to be used more frequently
in myocardial disease of uncertain origin (or the 'non-
coronary cardiomyopathies')," the early stages of the
disease could be detected without much harm to the
patient. Hopefully, the future wiJJ produce specific thera-
peutic regimens to counteract this uniformly fatal albeit
rare condition.
Prognosis
The outlook is uniformly poor, and death usuaJJy results
from congestive cardiac failure despitl: energetic treat-
ment. Some author ,. have reported a survival time
following the onset of symptoms of 14 months to 5 years,
with an average of 32 months.'· The patient may die of
an acute pulmonary embolism, renal failure or, more
rarely, coronary embolism. In one series," 29% (8
patients) died suddenly and inexplicably. Three of these
had myeloma-associated amyloidosis, 4 had primary
amyloidosis, and 1 had econdary amyloidosis. Digitalis-
induced arrhythmias were thought to have been the
cause of death. The poor prognosis in primary amyloi-
dosis associated with multiple myelomatosis was thought
to be an indication of the. underlying hJalignancy per se.
Kyle and Bayrd' divided their group of 193 patients into
those with primary amyloidosis (132 cases) and amyloi-
dosis associated with multiple myeloma (61 cases).
Patients in the former group had a median (50%) survi-
val of 14,7 months, while those in the latter group had
a survival of 4 months after histological diagnosis of
amyloidosis. The major cause of death in this series was
congestive cardiac failure in 30%.
Generally speaking, primary cardiac amyloidosis pro-
gresses more slowly than the secondary form, but the
former displays no regression, whereas the latter may
become reversible once the primary cause has been
effectively treated.
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